First European Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System
Stryker (NYSE:SYK) has completed the first European surgeries using its Gamma4 Hip Fracture Nailing System in Switzerland and France. The system, which treats hip and femur fractures, uses a design based on Stryker's extensive SOMA database. After obtaining CE certification in November 2023, it has been used in over 25,000 cases in North America and Japan.
Following the European debut, over 35 additional surgeries have been completed across several countries. A live broadcast event on June 4, 2024, in Germany will feature insights and case discussions led by esteemed faculty from across Europe.
- Completion of over 35 successful surgeries in Europe using Gamma4.
- CE certification received in November 2023.
- Gamma4 used in over 25,000 cases in North America and Japan.
- Live broadcast event planned for June 4, 2024, to discuss key insights and engineering philosophy.
- Positive feedback from European surgeons on system's tailored approach and procedural efficiency.
- The PR did not provide specific financial performance metrics or revenue figures associated with the Gamma4 system.
- The success of the European launch remains to be seen in terms of broader market adoption and sales impact.
Insights
The introduction of Stryker’s Gamma4 Hip Fracture Nailing System to the European market signifies a notable advancement in orthopedic surgery. Given the system's record of over 25,000 cases in North America and Japan, its performance data is well-documented and likely reliable. The utilization of Stryker's SOMA database, with its extensive collection of 3D bone models, enhances the system's ability to address diverse anatomical needs. The intuitive instrumentation and reduced surgical steps potentially lower the risk of intraoperative complications and improve recovery times, making the system attractive to surgeons and patients alike. However, we should be cautious about potential long-term outcomes and the learning curve associated with any new surgical equipment.
Stryker's expansion of the Gamma4 Hip Fracture Nailing System to Europe is likely to have a positive financial impact on the company's revenue streams. The European market's acceptance, following the system's success in the United States, North America and Japan, suggests a strong market demand and potential for significant sales growth. The CE certification, achieved in November 2023, supports the system's compliance with rigorous European standards, potentially boosting investor confidence. The upcoming live broadcast event and the participation of renowned faculty could further enhance market penetration and brand recognition. Investors should monitor the reception of this product closely, particularly initial sales figures and feedback from the European region, to gauge its sustained impact on Stryker’s financial performance.
With over 35 successful surgeries, the Gamma4 system will be launched in live broadcast event in
Stryker's Gamma4 Hip Fracture Nailing System is designed to treat hip and femur fractures. Its nail design is informed by Stryker's SOMA database, which includes over 37,000 3D bone models generated from CT scans. (Photo: Business Wire)
The Gamma4 Hip Fracture Nailing System is designed to treat hip and femur fractures. Its nail design is informed by Stryker's SOMA database, which includes over 37,000 3D bone models generated from CT scans. The system received CE certification in November 2023 and has been utilized in over 25,000 cases in
“This moment marks a significant milestone, as the Gamma4 Hip Fracture Nailing System enters the European market, following the successful launch in the United States,” said Markus Ochs, vice president and general manager of Stryker’s European Trauma & Extremities business. “This system represents Stryker’s unwavering commitment to innovation and excellence in providing advanced medical solutions, empowering surgeons worldwide with options designed to streamline operative flow and improve procedural efficiency.”
The first surgeries in
-
Professor Frank Beeres, Chefarzt, PD Dr. med. Björn-Christian Link, Chefarzt und Klinikleiter, Dr. med. Marcel Köppel and Dr. med. Ralf Baumgärtner from the Luzerner Kantonsspital LUKS,
Switzerland -
Professeur Daniel Wagner, Médecin chef de l'unité de Traumatologie and Docteur Kevin Moerenhout from Médecin Associé from CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne,
Switzerland -
Professeur Philippe Adam’s department at the Les Hôpitaux Universitaires de
Strasbourg, France
When asked about their experience, the Swiss surgeons agreed that Gamma4 allows for a tailored approach to each patient's unique anatomy and offers several key features to enhance surgical outcomes. The system's intuitive instrumentation streamlines procedures and reduces the number of surgical steps required. The surgeons noted the accuracy of the implant fit and the overall quality of the instruments.
Since these initial use cases, more than 35 additional surgeries utilizing the Gamma4 system have been completed in
During the live broadcast event scheduled for June 4, 2024, 17:30 CET, Stryker will share key insights and a deep dive into the Gamma4 engineering philosophy. Esteemed faculty, including Professor Dr. Gerhard Schmidmaier from University Hospital Heidelberg, PD Dr. Arvind G. Von Keudell from University Hospital Copenhagen, and Professor Dr. Julio de Caso Rodríguez from Hospital de la Santa Creu i Sant Pau in
To discover more about the Gamma4 Hip Fracture Nailing System, visit stryker.com.
About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Gamma4, Stryker. All other trademarks are trademarks of their respective owners or holders.
Copyright © 2024 Stryker
Content ID: G4-AD-15, 04-2024
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528327447/en/
Sampson Public Relations Group
Andrea Sampson
President/CEO
asampson@sampsonprgroup.com
Source: Stryker
FAQ
What surgeries were completed using Stryker's Gamma4 Hip Fracture Nailing System?
When will Stryker host the live broadcast about the Gamma4 system?
How many surgeries have been performed using Stryker's Gamma4 system globally?
What is the purpose of Stryker's Gamma4 Hip Fracture Nailing System?
Who provided positive feedback about the Gamma4 system?
